Luigi Atripaldi
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 detection and testing 5
- Viral gastroenteritis research and epidemiology 2
- HIV/AIDS drug development and treatment 2
-
- Hepatitis C virus research 6
- Co-authors
- Alessandro Perrella (13 shared papers)O. Perrella (10 shared papers)Costanza Sbreglia (9 shared papers)Carolina Rescigno (2 shared papers)Vincenzo Sangiovanni (2 shared papers)Michele Cennamo (1 shared paper)Francesco Bèguinot (1 shared paper)Francesco Oriente (1 shared paper)
In The Last Decade
Luigi Atripaldi
39 papers receiving 386 citations
Peers
Comparison fields: 5 of 68
- Hepatology 59
- Infectious Diseases 124
- Transplantation 10
- Molecular Medicine 19
- Modeling and Simulation 17
Countries citing papers authored by Luigi Atripaldi
This map shows the geographic impact of Luigi Atripaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Atripaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Atripaldi more than expected).
Fields of papers citing papers by Luigi Atripaldi
This network shows the impact of papers produced by Luigi Atripaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Atripaldi. The network helps show where Luigi Atripaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Luigi Atripaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 61 | |
| 2 | 2021 | 46 | |
| 3 | 2016 | 35 | |
| 4 | 2022 | 28 | |
| 5 | 2021 | 22 | |
| 6 | 2007 | 19 | |
| 7 | 2006 | 16 | |
| 8 | 2020 | 14 | |
| 9 | 2017 | 12 | |
| 10 | 2009 | 11 | |
| 11 | 2009 | 11 | |
| 12 | 2006 | 11 | |
| 13 | 2021 | 8 | |
| 14 | 2017 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2009 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2017 | 6 |
About Luigi Atripaldi
Luigi Atripaldi is a scholar working on Infectious Diseases, Hepatology, Surgery, Epidemiology and Immunology, having authored 41 papers that have together received 393 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (7 papers), Hepatitis C virus research (6 papers), SARS-CoV-2 detection and testing (5 papers), Long-Term Effects of COVID-19 (3 papers), Viral gastroenteritis research and epidemiology (2 papers), T-cell and B-cell Immunology (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Hepatology (59 citations), Infectious Diseases (124 citations), Transplantation (10 citations), Molecular Medicine (19 citations) and Modeling and Simulation (17 citations). Luigi Atripaldi has collaborated with scholars based in Italy and India. Frequent co-authors include Alessandro Perrella, O. Perrella, Costanza Sbreglia, Carolina Rescigno, Vincenzo Sangiovanni, Michele Cennamo, Francesco Bèguinot, Francesco Oriente, Emanuele Durante‐Mangoni and Vittoria D’Esposito. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Clinical Medicine, Frontiers in Pharmacology, Journal of Translational Medicine and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.